Directorate Change

Nigel Rogers steps down, concluding the Board succession plan

Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces that Keyvan Djamarani has been appointed as Independent Non-executive Director with immediate effect. This follows an extensive process led by an independent head-hunter. At the same time Nigel Rogers, who previously served time as Chair of the Company, will step down from the Board.

Keyvan has over 30 years' relevant experience, holding numerous leadership roles in product development within manufacturing organisations covering medical and pharmaceutical drug delivery devices. He has a track record of delivering increased sales, profitability and business critical programmes and projects. Most recently he spent over nine years as Managing Director/Business President at Bespak Europe, a medical and pharmaceutical drug delivery devices business. Keyvan began his career at Unilever working in their Detergents and Personal Products Divisions prior to joining Bespak. At Bespak, Keyvan held several roles across their European and North American divisions. Within this period, from 2002 to 2005, Keyvan was General Manager and President of Bespak Inc. and from 2010 to 2013, Keyvan became CEO of King Systems, an airways management business, encompassing design, development and manufacture of airway management products. Keyvan was most recently a Non-executive Director of CEME Ltd, a not-for-profit business enterprise operating on a 19-acre campus, home to over 100 engineering, technology and training businesses - a role he held for over 16 years.

As announced on 22 May 2023, Nigel Rogers will step down from the Board with immediate effect, concluding the final part of the planned Board succession process. Nigel joined the Board in 2015, bringing stability to the Company at a critical time.

Chair of the Company, Jonathan Glenn, commented: "I would like to thank Nigel for the dedicated service he provided to Surgical Innovations over his eight-year tenure, bringing the Company safely through a number of significant challenges including the pandemic. His experience proved invaluable and his insight has always been appreciated by the Board and management.

"I am also delighted to welcome Keyvan to the Board. He has an excellent track record in the medical device sector and brings with him a broad and relevant skillset. His extensive operational experience will provide a wealth of expertise to the Board, affording valuable insight into the challenges of manufacturing as the Company undertakes a major efficiency drive to improve margins."

Dr Keyvan Mehdi Djamarani (aged 62) is currently, or has during the past five years, been a director of the following companies:

Save as set out in this announcement there are no further details to be disclosed in accordance with Rule 17 and Schedule Two Paragraph (g) of the AIM Rule for Companies.